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inTRoDucTion
Despite some differences in the clinical presentation, it is 
often difficult to differentiate between dementia with Lewy 
bodies (DLB) and clinical Alzheimer’s dementia (AD) or 
Parkinson’s disease dementia.1,2
A prominent example is that of the actor Robin Williams. 
With his first symptoms occurring in October 2013 
(sudden spikes in anxiety, constipation, urinary difficulty, 
heartburn, insomnia, a poor sense of smell, stress, and 
a slight tremor in his left hand), he eventually suffered 
from paranoia, delusions, severe insomnia, memory 
loss, and high cortisol levels indicating stress, before 
he committed suicide in August 2014.3 Originally diag-
nosed with Parkinson’s disease, his autopsy revealed that 
he had been suffering from DLB, explaining the under-
lying cause for his Parkinsonism, depression and memory 
loss.
In DLB, there is an accumulation of clumps of alphasy-
nuclein (Lewy bodies) in the neurons, first described in 
1912 by Friedrich Lewy.4 Typical Parkinsonian symptoms 
in DLB include reduced facial expression, stiffness, shuf-
fling gait with minimal arm swing, dysphonia, dysphagia 
and hypersalivation, whilst tremors are less common. 
Early differentiation is important as patients with DLB 
characteristically have a hypersensitivity to most anti-
emetic and neuroleptic drugs. These affect the cholin-
ergic and dopaminergic system, potentially leading to 
life-threatening catatonia, loss of cognitive function and 
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Despite some differences in clinical presentation, it is often difficult to differentiate between dementia with Lewy 
bodies (DLB), clinical Alzheimer’s dementia (AD) and Parkinson’s disease dementia. However, differentiation can be 
crucial, especially as patients with DLB characteristically have a hypersensitivity to most antiemetic and neuroleptic 
drugs as they affect the cholinergic and dopaminergic system, potentially leading to life-threatening catatonia, loss of 
cognitive function and muscle rigidity. The aim of this study is to evaluate if resting state (RS) functional MRI (fMRI) can 
be used in routine practice on a 1.5 T scanner to differentiate between AD and DLB on an individual basis. We age- and 
gender-matched a known DLB patient with an AD patient and a human control (HC). Individual independent compo-
nent analysis was carried out. Region of interest seeds were chosen from the midcingulate and insula regions. Func-
tional connectivity from insula to midcingulate and within the midcingulate network (part of the Salience network) 
was lower in DLB than AD or HC. RS-fMRI on a 1.5 T scanner, in a routine clinical setting, detected abnormal functional 
connectivity patterns and allowed differentiation of DLB and AD in a routine clinical setting. This is the first evaluation 
of RS-fMRI in a routine clinical setting. It shows that incorporating RS-fMRI into the clinical scanning protocol can assist 
in early diagnosis and likely assist in monitoring the natural history of the disease or disease modifying treatments.
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muscle rigidity. Some antidepressants and over-the-counter 
drug cold remedies may cause acute confusion, delusions, and 
hallucinations.2
A method that has been hailed as a potential biomarker for the 
early diagnosis of neurodegenerative disease is resting state 
functional MRI (RS-fMRI),5 but it has not yet been imple-
mented into a routine clinical setting. Instead of analysing a 
cohort of patients, this study intended to investigate the different 
functional connectivity (FC) patterns between AD, DLB and 
hehuman controls (HC) on an individual base to assist the early 
differential diagnosis of dementia.
MeThoDS anD MaTeRialS
Subjects
Subjects with mild severity of symptoms were chosen to best 
match the cohort that would necessitate differentiation. Selected 
subjects were recruited as part of a larger observational, cross-sec-
tional study (NCTO2736396  clinicaltrials. gov), reviewed and 
approved by our local ethics committee, and all subjects gave 
informed consent for participation.
In order to see if previously reported group findings could be 
transferred to individual patients in a real-world clinical setting, 
we selected an age- and gender-matched known DLB patient, 
AD patient and a healthy control. All subjects were right-
handed. The AD patient was on donepezil, and the DLB patient 
on rivastigmine.
Patients were recruited from the memory clinic or neurology 
clinic at  Southend University Hospital NHS Foundation Trust. 
The diagnosis was made on the basis of the clinical symptoms. 
Blood tests and MRI were performed to rule out other possible 
causes.
Subject 1 (AD)
The AD patient met National Institute of Neurological and 
Communicative Diseases and Stroke/Alzheimer’s Disease and 
Related Disorders Association criteria for probable AD.6 Symp-
toms started in his mid-50’s with forgetfulness and general poor 
short-term memory issues, which were a drastic change from his 
previous high level of functioning. A diagnosis of probable AD 
was given at age 60 with worsening short-term memory, some 
episodes of disorientation and some changes in personality. MRI 
showed progressive atrophy around the medial temporal lobes 
and also the hippocampus.
Subject 2 (DLB)
The DLB participant’s symptoms started at the age of 52 with 
forgetfulness, disorientation, and fluctuating cognition with great 
variations in attention, which sometimes left him being unable to 
respond to those around him. Probable DLB was diagnosed at 
age 63 after symptoms included visual hallucinations, visuoper-
ceptive difficulties and fluctuating cognition, the patient now 
meeting the consensus criteria for probable DLB which include 
the presence of two or more of the core clinical features: fluctu-
ating cognition, visual hallucinations and/or Parkinsonism.2
Subject 3 (HC)
The control was a right-handed, white British male with 22 
years of education (school, college, university and post-graduate 
education). The participant’s known medical history consisted 
of coeliac disease, erythromelalgia and borderline rheumatoid 
arthritis.
Neuropsychological evaluations
The Mini Mental State Examination (MMSE) was used to assess 
global cognition, whilst episodic memory was assessed with the 
Rey Auditory Verbal Learning Test (RAVLT). The Stroop test was 
used as a test of executive function, attention and concentration, 
with block colour, congruent colour–word pair, and incongruent 
colour–word pair tasks being completed. Finally, visual short-
term memory (VSTM)  was assessed using the VSTM assessment 
created by the Vision and Eye Research Unit at Anglia Ruskin 
University. Task 1 assessed object memory, Task 2 assessed loca-
tion memory, and Task 3 assessed object-location memory.
Additionally, the clinical dementia rating (CDR) was completed 
as a semi-structured interview to assess the severity of dementia 
and the Beck Depression Inventory—Second Edition (BDI-II) 
was used to identify depression.
Image acquisition
All structural and functional images were acquired on non-se-
dated patients on the same clinical 1.5 T MRI scanner (GE Signa 
Excite HDXT), not optimized for research, using an 8-channel 
high-resolution parallel imaging head coil. Subjects were 
instructed to lie still in the scanner and not to think of anything 
whilst keeping their eyes closed.
High-resolution T1  weighted three-dimensional fast spoiled 
gradient echo images were taken in order to obtain anatom-
ical images for core registration of the fMRI data, covering the 
head from foramen magnum to vertex. Voxel size of fast spoiled 
gradient echo images was 1 × 1 × 1 mm3.
An echo-planar imaging gradient echo sequence was used for the 
RS functional sequence. The number of volumes (time frames) 
collected was 200 with a field of view of 24 cm and a matrix size 
of 64 × 64. Number of slices was 32, slice thickness 5 mm (gap 
between slices = 0.5 mm), repetition time = 2.5 s. Average acqui-
sition time was 13 min.
Functional imaging analysis
No sequences needed repeating. RS-fMRI data were first 
corrected from cardiac and respiratory physiological noise using 
RETROICOR7 and RVHRCOR.8 Data preliminary processing 
was carried out using FMRIB Software Library (FSL):9 (1) 
slice timing correction for interleaved acquisitions; (2) head 
motion correction via a robust and accurate intramodal volume 
linear registration (MCFLIRT); (3) spatial smoothing with a 5 
mm FWHM Gaussian kernel; (4) high-pass temporal filtering 
(Gaussian-weighted least-squares straight line fitting, with σ = 
100 s); (5) spatial normalization via estimating a B-spline basis 
transformation from an individual functional space to MNI152 
standard brain space (FLIRT).
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Individual independent component analysis (ICA) was carried 
out using FSL Multivariate Exploratory Linear Decomposition 
into Independent Components. Each patient’s independent 
components were carefully inspected and noise components 
were noted and further by FSL function fsl_regilt to regress out 
noise components using ordinary least squares.
Region of interest (ROI) seeds were chosen from the midcin-
gulate and insula regions, which are part of the Anterior 
Salience Network. ROI masks were obtained from  findlab. 
stanford. edu.10 Mean time series from each ROI was used as 
input regressor to FSL FEAT in order to identify other voxels 
having similar spontaneous time course. Resulting z-statistic 
was threshold at 3.5.
ReSulTS
Neuropsychological evaluations
Regarding global cognition, the DLB patient scored the lowest 
with an MMSE score of 20, the AD patient scoring 25. The 
DLB patient had the highest scores on CDR global (1) and 
sum of boxes (5) assessment, showing a mild severity stage 
of dementia. The AD patient had a CDR global score of 
0.5, landing him in the early disease stage of  “questionable” 
severity.
Whilst the episodic memory, as measured by the encoding, 
immediate and delayed recall sections of the Rey Auditory 
Verbal Learning Test, was low in the DLB patient (encoding 
25, immediate recall 4, delayed recall 2, recognition 4), the 
AD patient had the lowest scores for: immediate (0) and 
delayed recall (1) and scored poorly in recognition (4) and 
encoding (16).
The DLB patient, when compared to the AD patient and HC, had 
the worst performance on the Stroop tasks: block (155 vs 49 vs 
34 s), congruent (159 vs 84 vs 22 s) incongruent (303 vs 81 vs 54 
s), whilst also making the only errors in the block colour (1) and 
incongruent colour-word tasks (11).
The DLB patient was unable to complete any of the VSTM tasks, 
as he did not meet the visual acuity requirements. The AD patient 
scored low on all VSTM tasks (Task 1: 81.25%, Task 2: 75.00%, 
Task 3: 50.00%), the HC reaching normal scores (Task 1: 93.75%, 
Task 2: 87.50%, Task 3: 62.50%).
BDI-II score in the DLB patient was 18, suggesting mild 
(BDI-II 14–19) depressive symptoms and 4 in the AD patient 
suggested minimal (BDI-II 0–13) depressive symptoms. The 
HC scored 0 on the CDR global and CDR sum of boxes and 
BDI-II assessments.
Neuropsychological findings are listed in Table 1.
RS-fMRI results
Salience network
Individual ICA from the ROI seeds from the midcingulate and 
insula regions showed:
1. FC within the midingulate network (part of anterior 
Salience network) was lower in the DLB patient compared 
to the AD patient (Figure 1) and HC (Figure 2).
2. FC from insula to midingulate was lower in the DLB patient 
compared to the AD patient (Figure 3) and HC (Figure 4). 
DiScuSSion
As the overlap of neuropathological, cognitive, emotional and 
motor symptoms make an accurate differential diagnosis diffi-
cult, DLB is often confused with Parkinson’s disease dementia, 
AD and/or vascular dementia, especially in the early stages of the 
disease. However, differentiation is important due to the charac-
teristic sensitivity of DLB patients to most neuroleptic and anti-
emetic drugs.1
Up to now, the neural changes responsible for the symptoms of 
attention deficits, motor features of Parkinsonism and depres-
sion that are characteristic of DLB are not well-understood.11 
Characteristic clinical symptoms associated with DLB are 
believed to correlate with FC within specific RS networks.11 
For example, Parkinson like symptoms in DLB correlate with 
structural pathology and neurotransmitter abnormalities in the 
Putamen,12 whilst emotional regulation and the high incidence 
of depression seen in DLB is associated with Basal ganglia and 
limbic networks, specifically the caudate.13 Fluctuating cogni-
tion, another frequent symptom of DLB,2 is linked to the key role 
the thalamus plays in maintaining consciousness.14 Attention 
deficits are greater in DLB than AD patients and are linked to the 
Salience and Executive networks.15 Depending on the severity 
and symptom profile, the salience, executive control, default 
mode network (DMN), basal ganglia and limbic networks should 
thus be more affected in DLB patients than in AD or HCs.
There are only a few studies16–19 that have investigated FC in DLB 
and none have looked at its value to assist in the differential diag-
nosis on an individual patient level. All previous analyses were 
done at a group level. In our analysis we tested the discriminative 
utility of RS-fMRI at the individual patient level, attempting to 
translate previous research findings into clinical practice with 
RS-fMRI as a potential further diagnostic biomarker.
Franciotti et al17 previously utilized the ICA method in DLB 
patients, but only described a lack of abnormalities in the DMN 
connectivity. No analysis of the salience network was reported. 
Galvin et al16 showed both increased FC with putamen and 
parietal regions and decreased connectivity with prefrontal 
and primary visual cortices when focusing solely on precuneus 
connectivity and using the whole structure as the seed region. 
Lowther et al11 showed less FC in DLB compared with AD 
patients and HC in the posterior DMN and increased FC in the 
posterior cingulate and putamen.
In our study, we followed a seed-based approach, with special 
focus on the salience network adapted from Lowther et al.11 ROI 
seeds were chosen from the midcingulate and insula regions (part 
of the Anterior Salience Network). Our study showed that the 
DLB patient distinctly differed in FC within the salience network 
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compared to the AD patient and control, with decreased FC 
from insula to midcingulate and within the midcingulate region. 
Similar to our findings (less connectivity in DLB), previous 
studies20 have shown enhanced FC of salience networks in AD. 
Lowther et al11 has previously described less FC in a DLB group 
compared to AD and control groups in a number of brain regions. 
The authors had identified three ICs (IC 3,5,18) corresponding 
to brain regions known to be involved in salience and executive 
control.
The lower FC in the salience network in the DLB patient compared 
with HC and AD could be related to the characteristic symptoms 
we observed. Clinically, when compared to the AD patient, the DLB 
patient had severe impairment in executive function, attention and 
Table 1Demographic data and neuropsychological scores
AD DLB HC
Age 63 63 64
Education (years) 24 12 22
Global cognition MMSE 25 20 28
Severity of dementia
CDR global score 0.5 1 0
CDR sum of boxes 4 5 0
Episodic memory
RAVLT—encoding 16 25 48
RAVLT—immediate recall 0 4 9
RAVLT—delayed recall 1 2 8
RAVLT—recognition 4 4 12
Executive function, attention 
and concentration
Stroop—block (seconds) 49 155 34
Stroop—block (errors) 0 1 0
Stroop—congruent 
(seconds) 84 159 22
Stroop—congruent (errors) 0 0 0
Stroop—incongruent 
(seconds) 81 303 54
Stroop—incongruent 
(errors) 0 11 0
Visual short-term memory VSTM Task 1 (percentage) 81.25 –a 93.75
VSTM Task 2 (percentage) 75 – 87.50
VSTM Task 3 (percentage) 50 – 62.50
Depression BDI-II 4 18 0
AD, Alzheimer disease; BDI-II, Beck Depression Inventory; CDR, clinical dementia rating; DLB, dementia with Lewy bodies; MMSE, Mini-Mental State 
Examination; RAVLT, Rey Auditory Verbal Learning Test; VSTM, Visual Short-Term Memory.
BDI-II, 0–13: minimal depression; 14–19: mild depression; 20–28: moderate depression; 29–63: severe depression.
CDR: 0 = normal; 0.5 = very mild dementia; 1 = mild dementia; 2 = moderate dementia; 3 = severe dementia.
aThe DLB patient was unable to complete the VSTM tasks as did not meet the visual acuity requirements.
Figure 1. FC within the midcingulate network (part of Salience 
network) is lower in DLB than AD. White, midcingulate network 
mask; blue, AD; red-yellow, DLB. AD, Alzheimer disease; DLB, 
dementia with Lewy bodies; FC, functional connectivity.
Figure 2. FC within the midcingulate network (part of Sali-
ence network) is lower in DLB than HC. White, midcingulate 
network mask; Blue, HC; red-yellow, DLB. DLB, dementia with 
Lewy bodies; FC, functional connectivity.
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concentration, which was mirrored in a very poor performance 
on the Stroop tasks, both regarding time and errors, whilst short-
term memory and orientation to time and place remained intact. 
Our DLB patient had problems with figure copying (visuospatial 
impairment) and difficulty with serial sevens, most likely as a result 
of impaired attention. A correlation between severity of symptoms 
and FC in DLB has previously been described with higher FC in 
the less affected group.11 Interestingly, a recent study in ADHD 
patients also showed an association with decreased FC between the 
salience and executive control networks as well as with peripheral 
brain regions, underpinning the association between attention and 
the Salience network.21
We deliberately chose subjects with mild severity of symptoms, 
as this would best replicate the cohort of patient that clinically 
necessitates differentiation. Regarding global cognition, both 
were not severely affected (MMSE 20 and 25), the DLB patient 
showing a mild severity stage of dementia, the AD patient being 
in the early disease stage of “questionable” severity.
Our findings are consistent with previous results in that we 
also showed less connectivity in DLB subjects compared with 
controls and AD in the salience network. We were able to iden-
tify distinct patterns of activity in FC that may assist in discrim-
ination of dementia with Lewy bodies from Alzheimer’s disease 
and cognitively normal patients.
Study limitations
Until autopsy, a definite diagnosis will not be possible. However, 
experienced clinicians diligently examined all subjects, coming 
to a consensus diagnosis. No CSF sampling or genetic analysis 
was performed. However, currently there are no broadly appli-
cable biomarkers for DLB and it seems premature to perform 
genetic testing in routine clinical setting for the diagnosis of the 
disease.
Although subjects were well matched for gender, age and hand-
edness and there was no significant impairment in global cogni-
tion, the DLB patient had less years of education. Our results 
show that it was possible to differentiate between DLB, AD and 
human controls on an individual basis. However, further large 
scale studies on individually matched patients would be neces-
sary to further validate this method.
Lorenzi et al22 previously reported that AD patients on meman-
tine exhibited increased connectivity. In our study, none of the 
patient were on memantine but they were not medication free. 
Thus, potential interaction of the medication with FC connectivity 
cannot be excluded.
The range of the neuropsychological test battery was limited 
to not significantly exceed 1 h in order to minimize stress and 
cognitive burden to the patients. They do, however, cover a broad 
range of cognitive domains and were all conducted by the same 
experienced rater.
Only 200 acquisitions were obtained to not impact routine clin-
ical scanning and limit the time a patient would need to be in the 
scanner.
Although subjects were instructed to not think of anything 
whilst in the scanner, it is impossible to control brain activity. 
However, we see the advantages of RS-fMRI in its non-invasive 
nature, the short time of image acquisition (10–13 min), the fact 
that no specific task is necessary and that patients who are too 
severely affected to actively cooperate in task-based fMRI study 
can be successfully evaluated.
We did not perform a correction for atrophy as, in accordance 
with Balthazar et al,23 this would not be useful in the context of 
finding a biomarker in routine clinical setting.
We only evaluated the salience network, whilst other RS 
networks might also be affected in DLB and AD. However, 
the aim of this study was to assess the individual patient, 
focusing on the patient’s specific symptoms, with the aim 
of generating data to assist the individual diagnosis. Future 
cohort studies can focus on the different networks and their 
role in neurodegenerative disease as well as structural change. 
A larger data pool from routine clinical practice can further 
our understanding of neurodegenerative diseases. Possibly, in 
the future, a common platform collection of biomarkers and 
outcome measures can be created, which would likely expedite 
clinical–translational research. Consideration might be given 
to establishing a national server and creating a plan for reim-
bursement of biomarkers as well as support for an interdisci-
plinary collaboration.
Figure 3. FC from insula to midcingulate is lower in the patient 
with DLB than in the patient with AD. White, insula mask; Blue, 
AD; red-yellow, DLB. AD, Alzheimer disease; DLB, dementia 
with Lewy bodies; FC, functional connectivity.
Figure 4. FC from insula to midcingulate is lower in the patient 
with DLB than in the HC. White, insula mask; green, HC; 
red-yellow, DLB, dementia with Lewy bodies.
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concluSion
We were able to show that individual measures within the 
salience network allow differentiation between DLB, AD and 
normal ageing, even in clinically mild cases, in a routine clinical 
setting on a 1.5 T scanner. RS-fMRI has the potential to serve 
as an early biomarker to distinguish AD from DLB and HC. We 
hope that our work inspires future studies in a routine clinical 
setting to provide more evidence for the strength of this method.
leaRninG PoinTS
1. RS-fMRI can be performed in routine clinical setting on a 
1.5 T MRI scanner.
2. RS-fMRI can be useful in differentiating between different 
neurodegenerative diseases
3. RS-fMRI has the potential to serve as an early biomarker 
for AD.
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